Drug intelligence / Profile preview

cimicifuga foetida

Development stage
Unknown
Administration
Oral
01

Overview

**Cimicifuga foetida** is a perennial herb used in Traditional Chinese Medicine (TCM), where its rhizome, known as Sheng Ma or Cimicifugae Rhizoma, is pungent, slightly sweet, and cold, entering the lung, spleen, stomach, and large intestine meridians. It effuses the external to outthrust rashes, clears heat and detoxifies, and invigorates Yang, treating wind-heat headache, toothache, aphtha, sore throat, uterine prolapse, anal prolapse, early-stage measles, chills, fever, and diarrhea due to Spleen Qi deficiency. Phytochemically, it contains over 348 compounds, primarily 9,19-cycloartane triterpenoid saponins (e.g., foetidinol-type), phenylpropanoids (e.g., ferulic acid), chromones (e.g., cimifugin), alkaloids, terpenoids, and flavonoids, which contribute to its anti-inflammatory, antitumor, antiviral, antioxidant, neuroprotective, anti-osteoporosis, analgesic, and antipyretic effects. Modern studies support its efficacy in menopausal symptoms, with extracts shown safe and effective in clinical trials, though large doses may cause nausea, dizziness, or miscarriage risk; pregnant/lactating women should avoid it.[1][2][3][5]

Other names
sheng macimicifugae rhizoma
02

Targets

CB (Cannabinoid receptors)ESR1 (ERα)

Beyond the preview

Go deeper on cimicifuga foetida.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on cimicifuga foetida.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call